However, no significant difference in mortality found between remdesivir and placebo groups
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 5 to 9, 2020. This …
Manufacturer Prices for Insulin Substantially Higher in the U.S.
Manufacturer prices more than eight times higher in the U.S. than in other high-income countries
Factors Associated With Suicide in Leukemia Identified
Risk factors include male sex, older age at diagnosis, White race
Psychosocial Resilience Linked to Heart Health in Black Adults
Individual psychosocial resilience independently linked to higher LS7 score in Black adults
Suicide Deaths Up in Youth After Antidepressant Warnings
After warnings and abrupt decline in treatment, downward trend of suicide deaths was reversed
Bimodal Neuromodulation Device May Relieve Tinnitus Symptoms
Therapeutic improvements continued for 12 months after treatment with bimodal stimulation
Physical Activity, Sleep Profiles Vary in Adults With Arthritis
Balanced activity profile linked to weaker work-related sitting habit, stronger outside walking habit
COVID-19 Symptoms Often Prolonged in Pregnant Women
Most prevalent first symptoms cough, sore throat, body aches, fever for those testing positive for SARS-CoV-2
Lifetime Prevalence of Suicide Ideation 17.4 Percent Among Doctors
Lifetime prevalence of suicide attempts 1.8 percent, with one-year prevalence of 0.3 percent